Skip to main content
Biological Psychiatry Global Open Science logoLink to Biological Psychiatry Global Open Science
. 2026 Jun 4;6(5):100764. doi: 10.1016/j.bpsgos.2026.100764

Retinal Origins of Aberrant Salience in Schizophrenia: The Perceptual Theory

Petr Adámek a,b,c,d,, Veronika Rudolfová a, Kristýna Malenínská a,e, Jiří Horáček a,b
PMCID: PMC13380484  PMID: 42471972

Abstract

In schizophrenia research, visual processing abnormalities have traditionally been viewed as downstream consequences of cortical dysfunction. However, the epidemiological observation that congenital cortical blindness appears to confer protection against schizophrenia, while peripheral blindness, regardless of its developmental timing, does not, indicates that visual input itself may play a more fundamental role in disease pathogenesis. Here we propose the Perceptual Theory of Schizophrenia (PerTh), a framework positing that instability in retinal dopamine signaling acts as an initiating mechanism in a subset of individuals. Retinal dopamine functions as a master gain controller, modulating receptive field properties and spatial frequency processing through D1 and D2 receptor–mediated mechanisms. We propose that schizophrenia-associated genetic liabilities, encompassing dopaminergic, GABAergic (gamma-aminobutyric acidergic), neuroimmune, and other risk factors, converge on retinal dopamine homeostasis, producing chronically unstable signals that corrupt the sensory foundation upon which predictive models of reality are built. This noisy input cascades through thalamocortical pathways, disrupting physical and cognitive salience formation; driving compensatory synaptic sprouting; and ultimately rendering diffuse, weak connections vulnerable to complement-mediated hyperpruning during adolescence. The framework integrates retinal electrophysiology, Bayesian predictive processing, and neurodevelopmental pruning mechanisms to explain symptom emergence timing, the predominance of auditory over visual hallucinations, and phenotypic heterogeneity. PerTh does not seek to replace existing dopaminergic, glutamatergic, neuroimmune, or neurodevelopmental models but instead complements them by identifying a potential upstream contribution originating in the visual periphery. This perspective generates testable predictions and points to novel research directions targeting retinal function in psychosis.

Keywords: Dopamine, Neurodevelopmental, Retina, Salience, Schizophrenia, Visual perception

Plain Language Summary

In this article, we propose a new theory about how schizophrenia develops, focusing on the retina’s role in visual processing. It suggests that unstable dopamine levels in the retina create noisy visual signals, which disrupt how the brain processes important information. These disruptions may lead to psychotic symptoms, such as delusions and hallucinations. The theory offers a fresh perspective on schizophrenia and highlights the need for research into retinal dysfunctions as a possible early contributor to the disorder’s development.

Plain Language Summary

In this article, we propose a new theory about how schizophrenia develops, focusing on the retina’s role in visual processing. It suggests that unstable dopamine levels in the retina create noisy visual signals, which disrupt how the brain processes important information. These disruptions may lead to psychotic symptoms, such as delusions and hallucinations. The theory offers a fresh perspective on schizophrenia and highlights the need for research into retinal dysfunctions as a possible early contributor to the disorder’s development.


Abnormalities of visual perception have increasingly been recognized in schizophrenia research. Early work emphasized magnocellular pathway impairments and low-level visual integration; more recent findings have extended these abnormalities to the retina itself, including altered contrast sensitivity, visual acuity, and electrophysiological responses (1, 2, 3). Such anomalies are traditionally seen as downstream consequences of cortical dysfunction rather than as contributors to disease etiology.

This view began to shift following epidemiological observations concerning congenital blindness. In a population-based cohort of >467,000 individuals, no schizophrenia cases were reported among 66 individuals with congenital cortical blindness, which is visual loss from bilateral occipital lesions while ocular structures remain intact. No comparable protection was observed for peripheral blindness arising from ocular dysfunction (4, 5, 6). These findings are statistically underpowered, given the rare comorbidity, and do not constitute definitive evidence. Nevertheless, the consistent absence of reported cases raises questions that existing models do not explicitly address.

This distinction between cortical and peripheral blindness is mechanistically significant for our framework. In congenital cortical blindness, retinal output remains intact at the eye but cannot reach the cortical areas where salience is computed and predictive models are formed. No retinal signal, whether noisy or clean, propagates through thalamocortical pathways to drive aberrant salience formation. In contrast, peripheral blindness arising from ocular dysfunction often preserves partial or qualitatively degraded retinal activity (7). According to the Perceptual Theory of Schizophrenia (PerTh), it is precisely such degraded but preserved retinal signaling that drives the pathogenic cascade. Causes of complete peripheral congenital blindness (e.g., bilateral anophthalmia) are too rare to permit epidemiological testing of whether the complete absence of retinal output, regardless of anatomical origin, would confer similar protection.

The relationship between visual function and psychosis risk is complex. Large longitudinal studies have yielded contradictory findings: In a Swedish cohort of >1 million men, it was found that poorer uncorrected visual acuity increased psychosis risk, while corrected refractive errors in a comparably sized Israeli cohort were associated with reduced schizophrenia risk (8,9). The discrepancy likely reflects whether corrected or uncorrected acuity was assessed, indicating that the critical variable is signal quality and stability rather than visual impairment per se. Recent Mendelian randomization analyses further indicate that schizophrenia may itself be a causal risk factor for poorer visual acuity (10). Such bidirectional patterns are consistent with retinal dopaminergic signaling acting as a shared mechanism, given its established role in regulating both contrast sensitivity and visual acuity.

Several questions emerge from these observations. Why do many individuals with schizophrenia exhibit visual processing deficits that appear to predate psychosis onset (11)? Why does the disorder typically manifest during adolescence, coinciding with critical periods of visual system maturation (12)? In addition, why do antipsychotics that target cortical and subcortical dopamine receptors (13) also affect retinal contrast sensitivity (14, 15, 16, 17)? The literature shows some heterogeneity. Unmedicated first-episode patients tend to show elevated contrast sensitivity (18,19), whereas chronic medicated patients show reduced sensitivity that scales with antipsychotic dose (20,21). This pattern indicates that retinal dopamine plays a direct role in the pharmacological action of antipsychotics and that medication status is a critical confounder when interpreting contrast sensitivity findings in schizophrenia.

We propose PerTh, according to which in at least a subset of individuals, genetically driven instability in retinal dopamine signaling generates persistently noisy visual input that cascades through thalamocortical pathways, thereby disrupting salience formation and contributing to excessive synaptic pruning during adolescence (22). A schematic overview of the visual pathway and the proposed sequence of signal propagation is provided in Figure 1.

Figure 1.

Figure 1

The visual pathway and proposed sequence of aberrant signal propagation in the PerTh framework. (A) Anatomical overview of the 2 major visual processing streams. The dorsal stream (yellow) projects from the occipital lobe through the parietal cortex and processes spatial location and movement. The ventral stream (purple) projects from the occipital lobe through the temporal cortex and processes object identity and form. (B) Circuit organization and proposed PerTh cascade. Retinal ganglion cells project through P, M, and K channels to the LGN of the thalamus and onward to V1, V2, and the dorsal and ventral streams. The thalamic pulvinar provides additional connectivity between cortical visual areas and the frontal lobe. Numbered annotations indicate the proposed sequence of pathophysiological changes: 1) retinal dopamine instability generates an aberrant, noisy signal; 2a/2b) the thalamus and frontal lobe are among the first regions to show structural change as they fail to adapt to unstable input; 3a/3b) changes subsequently spread into the dorsal and ventral streams; 4, 5) V2 and V1 show later and typically smaller effects, consistent with their earlier developmental maturation and strong continuous sensory drive that preserves synaptic architecture. IPL, inferior parietal lobule; IT, inferior temporal cortex; LGN, lateral geniculate nucleus; P/M/K, parvocellular/magnocellular/koniocellular channels; PerTh, perceptual theory of schizophrenia; SPL, superior parietal lobule; V1, primary visual cortex; V2, secondary visual cortex; V4, visual area 4; V5/MT, middle temporal area.

This retina-first hypothesis does not seek to replace existing dopaminergic, glutamatergic, neuroimmune, or neurodevelopmental models. It complements them by highlighting a potential upstream contribution that has received relatively little attention. The framework generates falsifiable predictions and points to research directions targeting the visual periphery.

Situating PerTh Within Existing Theoretical Frameworks

Each of the current models of schizophrenia pathophysiology contribute important insights. The dopaminergic hypothesis highlights subcortical hyperdopaminergia and the efficacy of D2 receptor antagonists (23,24). Glutamatergic models emphasize NMDA receptor hypofunction and disrupted cortical inhibition (25,26). Neurodevelopmental accounts integrate genetic vulnerabilities with environmental factors and adolescent synaptic pruning (27). Neuroimmune models implicate complement-mediated synaptic elimination, microglial overactivation, and proinflammatory signaling, with C4A (complement component 4A) structural variants representing one of the strongest individual genetic risk factors identified to date (28).

Large-scale genomic studies have broadened this landscape. Genome-wide association study (GWAS) meta-analyses implicate >280 risk loci across dopaminergic, glutamatergic, synaptic, calcium channel, and transcriptional regulation genes (29). Postmortem transcriptomic analyses have revealed dysregulation of synaptic, mitochondrial, and immune modules (30). Single-cell analyses have shown schizophrenia polygenic risk converging on retinal amacrine cells (31). Thus, individual dopaminergic variants explain only a small fraction of disease risk, and pathogenesis involves convergent disruption across multiple molecular pathways.

Existing models have not explicitly addressed peripheral sensory processing, particularly retinal function, in disease pathogenesis. PerTh identifies an upstream contribution that interfaces with established frameworks: Chronically noisy retinal signals could contribute to the excitatory-inhibitory imbalance emphasized in glutamatergic models or represent a peripheral manifestation of the same genetic risk variants implicated in central dopaminergic dysfunction. Therefore, PerTh is complementary and applicable particularly to individuals with prominent visual processing abnormalities.

We acknowledge that direct evidence causally linking each stage of the proposed cascade remains limited. Each cascade element, such as retinal dopamine dysfunction, visual processing deficits, aberrant salience, and excessive synaptic pruning, is independently supported empirically in schizophrenia, but their sequential causal relationships have not yet been established. Therefore, the framework represents mechanistically plausible but empirically unproven causal links requiring coordinated validation. We outline such a research program in Future Research Directions, with testable predictions probing each cascade stage independently and in sequence.

The Retinal Dopamine Cascade: From Retinal Dysfunction to Psychosis

Current theories treat sensory abnormalities as downstream consequences of cortical or subcortical dysfunction. However, the cortical blindness paradox suggests that vision itself may be a primary driver of schizophrenia. This reframing, with sensory dysfunction at the beginning rather than the end of the pathological sequence, may explain why absence of visual processing is linked to reduced schizophrenia risk. We propose a 4-stage mechanistic cascade linking retinal dopamine dysfunction to schizophrenia symptomatology, grounded in molecular and cellular mechanisms (Figure 2).

Figure 2.

Figure 2

Retinal-origin cascade linking early visual dysfunction to adolescent synaptic pruning and schizophrenia onset. The figure summarizes the framework detailed in the article (see stages 1–4 in The Retinal Dopamine Cascade: From Retinal Dysfunction to Psychosis). C4A, complement component 4A; HC, healthy control; MD, mediodorsal thalamus; PFC, prefrontal cortex; SCHZ, schizophrenia; SF, spatial frequency; SV2A, synaptic vesicle glycoprotein 2A.

Stage 1: Retinal Dopamine Instability—A Proposed Initiating Mechanism

Molecular Architecture of Retinal Dopamine

The retina contains the highest peripheral dopamine concentration outside the central nervous system (32), synthesized by dopaminergic amacrine cells (DACs) located between the inner nuclear and plexiform layers (33). Although DACs constitute <1% of all retinal cells, they exert disproportionately broad influence through volume transmission. Dopamine released extrasynaptically reaches receptors across all retinal layers and virtually all neuronal classes (34,35). In the primate retina, DACs are absent from the foveola but reach peak density in a parafoveal ring approximately 2 to 3 mm from the fovea, with density declining toward the midperipheral retina (36,37). Combined with volume transmission, this distribution makes dopaminergic modulation most prominent in macular and parafoveal circuits and weaker peripherally. Retinal dopamine acts via D1 receptors on bipolar, horizontal, amacrine, and ganglion cells and via D2 receptors on photoreceptors and DACs themselves (34, 38) (Figure 3).

Figure 3.

Figure 3

Retinal dopamine gain control across bright light and low light conditions. The figure summarizes the proposed role of dopamine as a master retinal gain controller that strengthens surrounds in bright conditions and relaxes them in darkness, thereby regulating spatial-frequency sampling from coarse to fine detail. Schematic of retinal circuitry from outer to inner layers (ONL, OPL, INL, IPL, GCL) with OFF/ON IPL sublaminae. Left: bright light (photopic). Right: low light (mesopic-scotopic). Cones drive ON CBCs via HCs, amacrine cells, and DACs. In bright light, higher dopamine tone (turquoise dots) from amacrine sources increases D1 receptor signaling on BCs, HCs, DACs, and GCs and strengthens receptive-field surrounds (push-pull gain). In low light, dopamine tone falls, D1–dependent surround antagonism weakens, and network coupling/gap-junction state shifts accordingly. The inset at right illustrates the corresponding change in receptive-field size. CBC, cone bipolar cell; DAC, dopaminergic amacrine cell; GCL, ganglion cell layer; HC, horizontal cell; INL, inner nuclear layer; IPL, inner plexiform layer; ipRGC, intrinsically photosensitive retinal ganglion cell; ONL, outer nuclear layer; OPL, outer plexiform layer.

The Gain Control Mechanism

Retinal dopamine functions as a master gain controller, adjusting visual sensitivity to ambient conditions and behavioral demands. In cone bipolar and ganglion cells, D1–mediated modulation of GABAA (gamma-aminobutyric acid A) receptors via PKA (protein kinase A) phosphorylation adjusts receptive-field surround strength, strengthening surround antagonism under bright conditions and weakening it in darkness (39) (Figure 3). This produces push-pull spatial frequency tuning. D2 receptors govern fine-detail processing at moderate-to-high frequencies (∼2.3 cycles/degree), and D1 receptors govern low-frequency coarse-feature sampling (∼0.5 cycles/degree) (40).

Genetic Vulnerability and Dopamine Instability

In genetically vulnerable individuals, schizophrenia-associated variants converge on retinal dopamine homeostasis. Classical dopaminergic variants such as COMT Val158Met (41) and DRD2 polymorphisms (42) represent one mechanism, but the vulnerability extends well beyond dopaminergic genes (43,44). Individual common variants confer modest effects, with the polygenic risk score explaining approximately 7% of liability variance, with single nucleotide polymorphism–based heritability of 24% (29). These variants gain pathogenic relevance through convergent disruption of dopaminergic signaling, which we propose acts as a final common pathway integrating diverse genetic liabilities. GWAS-based cell-type enrichment analysis demonstrates that schizophrenia polygenic risk accumulates robustly in retinal amacrine cells, with associated genes including DRD2, CACNA1I (calcium voltage-gated channel), DOC2A (calcium-dependent neurotransmitter release), and SLC32A1 (vesicular GABA/glycine uptake) (31). The enrichment was not specific to any amacrine subtype, indicating that genetic vulnerability spans GABAergic and broader synaptic mechanisms converging on disrupted dopamine homeostasis. Pattern electroretinographya in healthy control participants demonstrates that even acute dopamine perturbations (e.g., D2 antagonism with sulpiride) selectively impair spatial frequency processing (17).

This genetic architecture helps explain why visual processing deficits in schizophrenia exceed what dopaminergic variants alone would predict. Several additional processes can independently disrupt retinal dopamine homeostasis. GABAergic dysregulation of amacrine networks destabilizes the timing and magnitude of DAC dopamine release. Neuroimmune activation involving microglial and complement-mediated mechanisms implicated in cortical pathology (28,45) affects retinal synaptic integrity. The retina’s high metabolic demand and light exposure render it susceptible to oxidative stress, which impairs dopamine synthesis and receptor function, while redox dysregulation has been proposed as a convergence hub for genetic and environmental risk (46). Epigenetic modifications linked to prenatal and early-life exposures further modulate dopaminergic and synaptic gene expression (47). These mechanisms likely operate in combination, with different pathways predominating across the heterogeneous schizophrenia population.

Stage 2: Noisy Visual Inputs and Aberrant Salience Formation

Salience comprises 2 components. Physical salience describes how certain stimulus features automatically capture attention through bottom-up, stimulus-driven processes independent of current goals (48). Cognitive salience involves top-down, goal-directed attention allocation guided by task demands or internal objectives (49). Because cognitive salience builds on physical salience, disrupted sensory sensitivity impairs the ability to attribute appropriate meaning to environmental stimuli (50).

Physical Salience Disruption

Unstable retinal dopamine creates inconsistent receptive field properties, generating noisy visual signals at cortical inputs. These fluctuations also affect spatial frequency processing. Low spatial frequencies (LSFs) carry coarse, global information about shape, orientation, and scene layout. High spatial frequencies (HSFs) carry fine-grained details such as edges, textures, and object features. LSF information is rapidly extracted (within 100–170 ms of stimulus onset) and transmitted to the prefrontal cortex, where it informs top-down predictions guiding attention, object recognition, and higher cognitive processes (51, 52, 53). Within the PerTh framework, unstable retinal gain control disrupts both LSF-based scene analysis and subsequent HSF-mediated refinement of percepts, impairing attentional capacity and the ability to rapidly incorporate salient percepts into the stream of consciousness (22).

Vision’s neuroanatomical dominance (54) makes it the primary sensory foundation for predictive models of reality. As the most peripheral component, the retina is the critical trigger point, and dysfunction here propagates through the entire visual hierarchy. In contrast, congenital deafness does not confer comparable protection against schizophrenia, with prevalence in prelingually deaf individuals matching the general population (55,56). The cortical versus peripheral distinction documented for blindness has no direct epidemiological counterpart for deafness, because central auditory disorders are anatomically rare and not separated from cochlear deafness in existing literature. The cochlea does receive dopaminergic input from the lateral olivocochlear system (57), but this neuromodulatory architecture is more circumscribed than retinal dopamine, which acts as a master gain controller across all major retinal cell types through volume transmission. The absence of a protective effect of deafness is thus consistent with this architectural difference and with vision’s substantially greater cortical representation.

Cascade to Cognitive Salience

As described previously (22), physical salience disruption prevents accurate cognitive salience formation. In Kapur’s framework (58), dysregulated dopamine alters the threshold at which sensory events become salient. PerTh identifies retinal dopamine as the source, with fluctuating gain control causing inappropriate “pop out” of irrelevant stimuli while failing to highlight informative signals. Perceptual organization deficits cause processing of object parts rather than unified wholes, activating inappropriate semantic associations and potentially explaining the loosening of associations and thought disorder characteristic of schizophrenia (59). Fragmented visual percepts thus cascade into language dysfunction, providing a mechanistic link between retinal dopamine instability and verbal-conceptual symptoms of psychosis.

Mental Model Instability

Inconsistent visual inputs corrupt formation of stable mental models. In the hierarchical Bayesian framework, the brain updates beliefs by combining sensory evidence with prior expectations, with dopamine modulating precision weighting (60). Retinal dopamine dysfunction introduces noise that prevents reliable signals from being distinguished from unreliable ones, forcing the developing brain to constantly revise priors based on corrupted data (22). Compensatory mechanisms paradoxically increase confidence in flawed models, treating uncertain inferences as highly precise predictions.

In the PerTh, Conrad’s delusional mood represents the moment when lifelong compensation fails under adolescent cognitive demands (61). Patients do not suddenly perceive novel abnormalities; they experience the conscious consequences of cumulative predictive failures. Because much early visual processing occurs outside awareness, high-risk individuals may not recognize that their experience differs from that of others (62). Retinal dysfunction, present since birth and perceptually normalized, cannot be identified as the source of mounting unease, and patients externalize the discrepancy as a diffuse change in the world. Crystallization into frank delusions during apophany represents a catastrophic attempt to resolve this uncertainty through explicit causal explanations (61,63).

Stage 3: Homeostatic Plasticity and Synaptic Architecture Changes

Compensatory Sprouting

Faced with inconsistent visual inputs, neurons cannot strengthen specific synaptic pathways through repeated activation. They compensate by forming numerous weak connections across many input sources, attempting to extract meaningful patterns from unreliable signals (64). Such incoherent input patterns can decouple strong synaptic connections and shift networks toward broadly distributed, low-strength connectivity (65), impairing signal-to-noise discrimination, reducing computational efficiency, and creating vulnerability to excessive pruning during adolescence.

Compensatory sprouting may appear to contradict the principle that biological systems minimize energy expenditure. However, we argue that sprouting driven by chronically noisy input is maladaptive rather than adaptive. Unlike homeostatic plasticity in intact circuits, which refines connectivity to maximize efficiency, the reorganization here generates diffuse, energetically costly circuits failing to achieve stable representations. Empirical evidence supports this. Unmedicated patients with active positive symptoms show elevated frontal cortical glucose metabolism (66), and hippocampal hypermetabolism appears in individuals at high risk for psychosis prior to onset (67). Long-term adaptation to noisy peripheral signals may eventually lead to neurotoxic processes and reduced pyramidal connectivity (1), with initial compensatory hypermetabolism giving way to the frontal hypometabolism and synaptic loss characteristic of chronic schizophrenia (68).

Circuit-Level Reorganization

Compensatory sprouting alters cortical circuit architecture, particularly in prefrontal regions where mental models of reality are maintained (69,70), providing a mechanistic explanation for the connectivity abnormalities observed in schizophrenia (71, 72, 73). Postmortem studies and in vivo positron emission tomography (PET) using the SV2A (synaptic vesicle glycoprotein 2A) biomarker confirm widespread reductions in synaptic density, with pronounced effects in the prefrontal and anterior cingulate cortices (74, 75, 76). These changes are present even in antipsychotic-naïve early-onset patients, indicating that they precede treatment and chronic illness (77,78). We propose that these synaptic alterations stem from the cascade of unstable bottom-up signals, manifesting most severely in prefrontal areas required to integrate degraded sensory information into coherent representations of reality.

Thalamocortical Disruption

Effects extend beyond the visual cortex through thalamocortical loops, particularly impacting the mediodorsal thalamus (MD) and its reciprocal connections with the prefrontal cortex. The lateral geniculate nucleus, receiving direct retinal input, must process increasingly noisy signals. Disruption propagates beyond visual pathways: The MD, an essential partner to the prefrontal cortex in cognition that amplifies cortical representations during demanding tasks, also receives degraded sensory information through corticothalamic feedback loops (79). This destabilizes not only visual processing but also the timing and coordination of thalamocortical oscillations critical for attention, working memory, and sensory gating. Computational models show that even modest increases in input noise can desynchronize thalamic relay neurons and corrupt cortical activation patterns (80, 81, 82).

Stage 4: Excessive Pruning and Symptom Emergence

The Adolescent Vulnerability Window

During adolescence, experience-dependent synaptic pruning refines cortical circuits by eliminating weak or unused connections while strengthening active ones (83,84). In healthy development, this is guided by consistent patterns of correlated activity reinforcing behaviorally relevant circuits (85). In individuals with retinal dopamine dysfunction, the cortex has already adapted to chronically noisy inputs through homeostatic mechanisms. Drawing on principles of structural homeostasis (64), we propose that persistent visual signal instability drives pyramidal neurons to form numerous but weaker contacts attempting to maintain stable activity (65). During adolescence, these diffusely connected, low-strength synapses are preferentially eliminated through activity-dependent pruning (85,86).

Complement-Mediated Hyperpruning

Genetic vulnerabilities amplify this process through the complement system, which tags synapses for microglial elimination during development (45,87, 88, 89). Schizophrenia-associated C4A variants increasing C4A expression are associated with elevated disease risk (28,90). However, high C4A expression alone is insufficient, as many unaffected individuals carry high-expression variants, and the relationship between C4A levels and brain volume differs between patients and healthy control participants, indicating compensatory mechanisms in resilient individuals (91,92).

We propose that retinal dopamine dysfunction provides the critical second hit; chronically noisy visual inputs drive formation of diffuse, weak synaptic connections; and high C4A expression amplifies vulnerability only when combined with this weakened architecture. The SV2A PET evidence of synaptic loss in antipsychotic-naïve patients (stage 3) is consistent with early hyperpruning of compromised circuits.

From Synaptic Loss to Symptom Emergence

Longitudinal neuroimaging in patients with schizophrenia reveals that gray matter loss follows a specific spatiotemporal pattern, beginning in thalamic hubs before cascading into frontal, temporal, and parietal cortices (93,94). Relative sparing of occipital and early visual cortex, despite a hypothesized retinal contribution, is consistent with the predominance of abnormalities in heteromodal temporofrontal cortices (95) and with the heterogeneous, often smaller, occipital effects reported (96). This pattern aligns with homeostatic plasticity principles; regions receiving strong, continuous sensory drive maintain synaptic strength via activity-dependent global synaptic scaling (97). Developmentally, occipital regions complete key pruning phases by early adolescence, whereas the prefrontal cortex remains plastic into late adolescence and the third decade (98,99). Therefore, dysfunction originating in visual pathways spreads through anatomically connected regions, with timing determined by each area’s developmental trajectory and pruning schedule (1).

As excessive pruning reduces synaptic density below critical thresholds, structural loss translates into psychotic symptoms. Subtle cognitive inefficiencies are detectable during childhood, before clinical diagnosis (100). During adolescence and early adulthood, accelerating aberrant pruning generates positive symptoms acutely through immediate perceptual misinterpretation and sustained cognitive elaboration into delusions, reflecting predictive machinery struggling to maintain coherence with unreliable inputs precisely when complement-mediated synaptic elimination peaks.

As illness progresses, negative symptoms (avolition, alogia, anhedonia, social withdrawal, and diminished emotional expression) become prominent. These arise from cumulative loss of cortical computational capacity through excessive pruning combined with disrupted local excitatory-inhibitory balance. Loss of GABAergic interneuron function and altered pyramidal connectivity impairs prefrontal-limbic circuits regulating motivation and emotional expression (101,102). In approximately half of patients, negative symptoms persist throughout the illness course, reflecting irreversible loss of synaptic infrastructure (103). Cognitive symptoms become apparent as adult demands exceed diminished capacity, reflecting convergence of original noisy signal processing, hyperpruning-driven synaptic loss, and disruption of thalamocortical oscillations essential for working memory and attention.

Within this framework, the relapsing-remitting course of schizophrenia reflects structural vulnerability established by excessive pruning. Once synaptic density falls below critical thresholds, cortical circuits lack computational reserve to maintain stable processing under environmental challenge. Well-documented relapse precipitants, including psychosocial stress, sleep deprivation, and substance use (104,105), can overwhelm this diminished system. Striatal dopamine sensitization further enhances reactivity during acute episodes (106). Within the PerTh framework, retinal dopamine instability continues to act as a persistent source of degraded sensory input, while postonset relapses are primarily determined by the interaction between residual cortical capacity and environmental demands.

The Auditory Hallucination Paradox

If retinal dysfunction drives schizophrenia pathogenesis, why do patients predominantly report auditory rather than visual hallucinations? This paradox can be resolved by considering how sensory modalities undergo perceptual adaptation.

Visual disturbances developing gradually from childhood undergo perceptual normalization. The brain recalibrates baseline expectations to accommodate slowly deteriorating input, leaving patients unaware of lifelong deficits in contrast sensitivity or visual acuity (107). In contrast, auditory anomalies, particularly misattributed inner speech, emerge acutely and intermittently (108), resisting normalization and remaining consciously salient. Therefore, patients may report hearing voices while failing to recognize concurrent visual distortions that have been experienced since childhood.

Auditory hallucinations also typically arise from failures in self-monitoring of inner speech rather than peripheral sensory dysfunction (109,110). When forward model mechanisms fail to tag self-generated verbal thoughts as internal, these are experienced as external voices. Within the PerTh framework, retinal dopamine instability generates noisy visual signals that, through the cascade in stages 2 to 3, ultimately destabilize the self-monitoring circuits distinguishing internal from external signals. This mechanism is independent of retinal pathology, explaining why auditory symptoms predominate even when visual dysfunction initiates the pathogenic cascade. Evolutionary threat detection circuits may further amplify auditory anomalies, as ancestral survival depended on detecting auditory signals of predators or social threats (111, 112).

Future Research Directions

The PerTh framework generates testable predictions across multiple experimental scales. Four complementary approaches probe distinct cascade links: 1) noninvasive screening combining smooth pursuit eye tracking with longitudinal pattern electroretinography to establish retinal dopamine biomarkers in adolescents at psychosis risk; 2) chemogenetic manipulation of retinal DACs in animals during adolescence, testing whether retinal dopamine instability produces schizophrenia-relevant phenotypes following established neurodevelopmental criteria; 3) induced pluripotent stem cell–derived retinal cells from patients with schizophrenia to distinguish intrinsic cellular pathology from upstream dopaminergic dysregulation; and 4) intervention studies targeting retinal dopamine stabilization, complement-mediated pruning, or synaptic plasticity at developmentally specific windows. Detailed protocols are provided in the Supplement.

Limitations

Several limitations must be acknowledged. First, epidemiological evidence remains statistically inconclusive. Danish register data following 460 cases of early blindness across 2,500,332 individuals found fewer than 5 schizophrenia cases (113). Power calculations indicate that demonstrating complete protection would require approximately 3 million individuals, while detecting 50% risk reduction would require approximately 11 million. Larger international collaborations would be necessary for cortical blindness specifically.

Second, current data cannot exclude the possibility that retinal and central dopamine dysfunction occur in parallel rather than sequentially. Schizophrenia-associated variants affecting dopamine metabolism could simultaneously alter retinal and brain dopaminergic signaling, making retinal changes a biomarker rather than a causal driver. If the absence of schizophrenia in congenital cortical blindness is confirmed in larger studies, this would indicate that visual input itself, not parallel dopaminergic dysfunction, is necessary for disease expression in at least some individuals.

Third, schizophrenia’s heterogeneity challenges any unifying model. Visual symptoms occur in approximately 60% of cases (114), ranging from 4% to 80.3% across studies depending on assessment and onset (115,116). Large-scale GWASs implicate glutamatergic genes (e.g., GRIN2A) at least as strongly as dopaminergic ones (29,117). Within the PerTh framework, glutamatergic dysfunction represents one of several upstream contributors converging on retinal dopamine homeostasis (stage 1). The framework is most directly applicable to individuals with prominent retinal dopamine instability, irrespective of which upstream genetic pathway predominates.

Fourth, complement-mediated hyperpruning is not unique to schizophrenia. Excessive synaptic elimination has been implicated in bipolar disorder with psychotic features, and C4A expression correlates with delusion severity across psychotic disorders (118). We propose that the schizophrenia phenotype emerges from combined excessive pruning and lifelong accumulation of aberrant salience signals from retinal dopamine instability, distinguishing it from bipolar disorder, in which hyperpruning may interact with affective circuit dysregulation to produce episodic rather than chronic psychosis.

Finally, the mechanism underlying symptom variability remains unclear. Retinal dysfunction may cause simple visual phenomena, while complex hallucinations require additional cortical disruption (119). Outcomes ranging from minor distortions to frank psychosis probably reflect interactions between retinal dysfunction and modifying factors, including polygenic risk burden, cognitive reserve (120), developmental stress exposure (121), and endophenotypic variation in sensory processing (122).

Conclusions

The PerTh framework offers a perspective on schizophrenia pathogenesis in which sensory processing abnormalities, specifically retinal dopamine instability, contribute to disease development in a subset of individuals rather than merely representing downstream consequences of cortical dysfunction. While epidemiological observations regarding congenital cortical blindness remain statistically underpowered, they raise questions warranting further investigation.

Whether the PerTh represents a schizophrenia-specific mechanism or a transdiagnostic vulnerability for psychosis is a key issue to explore. Retinal abnormalities clearly extend beyond schizophrenia. Optical coherence tomography meta-analyses have documented retinal nerve fiber layer and ganglion cell layer thinning in both schizophrenia and bipolar disorder (123,124). Electroretinogram profiles overlap across these disorders but show partially distinct patterns (125). Psychophysical deficits including impaired contrast sensitivity surround suppression (126), visual backward masking (127), and contour integration (128) correlate with psychosis severity independently of diagnosis. Notably, visual backward-masking deficits are present in schizoaffective and bipolar disorder but not in depression or abstinent alcoholics (129), indicating that these impairments track psychosis liability rather than psychiatric illness in general. However, recent GWAS-based cell-type enrichment analysis shows schizophrenia polygenic risk converging robustly on retinal amacrine cells, whereas bipolar disorder shows no consistent retinal cell-type association (31). Therefore, the genetic architecture appears to be at least partially diagnosis specific. We propose PerTh as primarily applicable to the schizophrenia spectrum, while retinal dopamine instability may represent a broader predisposing factor whose clinical expression is shaped by additional genetic, epigenetic, and environmental modulators. Longitudinal retinal biomarker studies spanning the psychosis spectrum represent a priority for testing this hypothesis.

Ultimately, the value of PerTh lies not in claiming to explain all cases of schizophrenia but rather in stimulating new research directions examining peripheral sensory processing in psychosis development. By directing attention to retinal function as a potential contributor to, rather than merely a marker of, disease pathophysiology, we hope to open new avenues for understanding the origins of this devastating disorder.

Acknowledgments and Disclosures

This work was supported by the Charles University research program Cooperatio-Neurosciences (Grant No. 1070119 [to PA]), the Czech Health Research Council (Grant No. NW25J-04-00110 [to KM and PA]), European Regional Development Fund-Project Brain Dynamics (Grant No. CZ.02.01.01/00/22_008/0004643 [to JH]), the institutional program of support of the Ministry of Health of the Czech Republic (MH CZ–DRO) (National Institute of Mental Health [NUDZ], Grant No. 00023752 [to PA]), and the Fulbright Program Czech (to PA).

We thank Professor Steven Silverstein for his invaluable consultations during the development of this new theory and for his insightful comments on the article. His pioneering research on retinal abnormalities in patients with schizophrenia has been a major source of inspiration for this work; without his contributions, this theory could not have been formulated.

PA and JH provided theory formulation. PA created the article illustration. PA, VR, and KM wrote the original draft of the article. JH, VR, and KM reviewed and edited the article.

The authors report no biomedical financial interests or potential conflicts of interest.

The authors used Claude (Anthropic) as a writing assistant for language editing, proofreading, and revision of article structure during the response to peer review. The tool was used under continuous author supervision; all scientific content, interpretations, and conclusions are the authors’ own, and the authors take full responsibility for the final article.

Supplementary material cited in this article is available online at https://doi.org/10.1016/j.bpsgos.2026.100764.

a

Noninvasive technique measuring retinal ganglion cell function.

Supplementary Material

Supplemental Text
mmc1.pdf (189.4KB, pdf)

References

  • 1.Adámek P., Langová V., Horáček J. Early-stage visual perception impairment in schizophrenia, bottom-up and back again. Schizophrenia. 2022;8:27. doi: 10.1038/s41537-022-00237-9. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 2.Moreno-Küstner B., Martín C., Pastor L. Prevalence of psychotic disorders and its association with methodological issues. A systematic review and meta-analyses. PLoS One. 2018;13 doi: 10.1371/journal.pone.0195687. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3.Solmi M., Seitidis G., Mavridis D., Correll C.U., Dragioti E., Guimond S., et al. Incidence, prevalence, and global burden of schizophrenia—data, with critical appraisal, from the Global Burden of Disease (GBD) 2019. Mol Psychiatry. 2023;28:5319–5327. doi: 10.1038/s41380-023-02138-4. [DOI] [PubMed] [Google Scholar]
  • 4.Morgan V.A., Clark M., Crewe J., Valuri G., Mackey D.A., Badcock J.C., Jablensky A. Congenital blindness is protective for schizophrenia and other psychotic illness. A whole-population study. Schizophr Res. 2018;202:414–416. doi: 10.1016/j.schres.2018.06.061. [DOI] [PubMed] [Google Scholar]
  • 5.Pollak T.A., Corlett P.R. Blindness, psychosis, and the visual construction of the world. Schizophr Bull. 2020;46:1418–1425. doi: 10.1093/schbul/sbz098. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Silverstein S.M., Wang Y., Keane B.P. Cognitive and neuroplasticity mechanisms by which congenital or early blindness may confer a protective effect against schizophrenia. Front Psychology. 2013;3:624. doi: 10.3389/fpsyg.2012.00624. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 7.Castaldi E., Cicchini G.M., Falsini B., Binda P., Morrone M.C. Residual visual responses in patients with retinitis pigmentosa revealed by functional magnetic resonance imaging. Trans Vis Sci Tech. 2019;8 doi: 10.1167/tvst.8.6.44. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 8.Caspi A., Vishne T., Reichenberg A., Weiser M., Dishon A., Lubin G., et al. Refractive errors and schizophrenia. Schizophr Res. 2009;107:238–241. doi: 10.1016/j.schres.2008.09.022. [DOI] [PubMed] [Google Scholar]
  • 9.Hayes J.F., Picot S., Osborn D.P.J., Lewis G., Dalman C., Lundin A. Visual acuity in late adolescence and future psychosis risk in a cohort of 1 million men. Schizophr Bull. 2019;45:571–578. doi: 10.1093/schbul/sby084. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 10.Shoham N., Dunca D., Cooper C., Hayes J.F., McQuillin A., Bass N., et al. Investigating the association between schizophrenia and distance visual acuity: Mendelian randomisation study [published correction appears in BJPsych Open 2024; 10:e73] BJPsych Open. 2023;9:e33. doi: 10.1192/bjo.2023.6. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 11.Klosterkötter J., Hellmich M., Steinmeyer E.M., Schultze-Lutter F. Diagnosing schizophrenia in the initial prodromal phase. Arch Gen Psychiatry. 2001;58:158–164. doi: 10.1001/archpsyc.58.2.158. [DOI] [PubMed] [Google Scholar]
  • 12.Tansey R., Graff K., Rai S., Merrikh D., Godfrey K.J., Vanderwal T., Bray S. Development of human visual cortical function: A scoping review of task- and naturalistic-fMRI studies through the interactive specialization and maturational frameworks. Neurosci Biobehav Rev. 2024;162 doi: 10.1016/j.neubiorev.2024.105729. [DOI] [PubMed] [Google Scholar]
  • 13.Horacek J., Bubenikova-Valesova V., Kopecek M., Palenicek T., Dockery C., Mohr P., Höschl C. Mechanism of action of atypical antipsychotic drugs and the neurobiology of schizophrenia. CNS Drugs. 2006;20:389–409. doi: 10.2165/00023210-200620050-00004. [DOI] [PubMed] [Google Scholar]
  • 14.Fornaro P., Calabria G., Corallo G., Picotti G.B. Pathogenesis of degenerative retinopathies induced by thioridazine and other antipsychotics: A dopamine hypothesis. Doc Ophthalmol. 2002;105:41–49. doi: 10.1023/a:1015768114192. [DOI] [PubMed] [Google Scholar]
  • 15.Harris J.P., Calvert J.E., Leendertz J.A., Phillipson O.T. The influence of dopamine on spatial vision. Eye. 1990;4:806–812. doi: 10.1038/eye.1990.127. [DOI] [PubMed] [Google Scholar]
  • 16.Perossini M., Fornaro P. Electroretinographic effects induced in humans by psychopharmacologic agents. Doc Ophthalmol. 1990;75:1–6. doi: 10.1007/BF00142587. [DOI] [PubMed] [Google Scholar]
  • 17.Stanzione P., Traversa R., Pierantozzi M., Semprini R., Marciani M.G., Bernardi G. An electrophysiological study of D2 dopaminergic actions in normal human retina: A tool in Parkinson’s disease. Neurosci Lett. 1992;140:125–128. doi: 10.1016/0304-3940(92)90697-6. [DOI] [PubMed] [Google Scholar]
  • 18.Kiss I., Fábián Á., Benedek G., Kéri S. When doors of perception open: Visual contrast sensitivity in never-medicated, first-episode schizophrenia. J Abnorm Psychol. 2010;119:586–593. doi: 10.1037/a0019610. [DOI] [PubMed] [Google Scholar]
  • 19.Kelemen O., Kiss I., Benedek G., Kéri S. Perceptual and cognitive effects of antipsychotics in first-episode schizophrenia: The potential impact of GABA concentration in the visual cortex. Prog Neuropsychopharmacol Biol Psychiatry. 2013;47:13–19. doi: 10.1016/j.pnpbp.2013.07.024. [DOI] [PubMed] [Google Scholar]
  • 20.Chen Y., Levy D.L., Sheremata S., Nakayama K., Matthysse S., Holzman P.S. Effects of typical, atypical, and no antipsychotic drugs on visual contrast detection in schizophrenia. Am J Psychiatry. 2003;160:1795–1801. doi: 10.1176/appi.ajp.160.10.1795. [DOI] [PubMed] [Google Scholar]
  • 21.Linares D., Joostens A., de la Malla C. A systematic review and meta-analysis on contrast sensitivity in schizophrenia. Schizophr Bull. 2025;51:1231–1241. doi: 10.1093/schbul/sbae194. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22.Adámek P., Grygarová D., Jajcay L., Bakštein E., Fürstová P., Juríčková V., et al. The gaze of schizophrenia patients captured by bottom-up saliency. Schizophrenia. 2024;10:21. doi: 10.1038/s41537-024-00438-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23.Howes O.D., McCutcheon R., Owen M.J., Murray R.M. The role of genes, stress, and dopamine in the development of schizophrenia. Biol Psychiatry. 2017;81:9–20. doi: 10.1016/j.biopsych.2016.07.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.McCutcheon R.A., Reis Marques T., Howes O.D. Schizophrenia—an overview. JAMA Psychiatry. 2020;77:201–210. doi: 10.1001/jamapsychiatry.2019.3360. [DOI] [PubMed] [Google Scholar]
  • 25.Javitt D.C., Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am J Psychiatry. 1991;148:1301–1308. doi: 10.1176/ajp.148.10.1301. [DOI] [PubMed] [Google Scholar]
  • 26.Lewis D.A. Cortical circuit dysfunction and cognitive deficits in schizophrenia—Implications for preemptive interventions. Eur J Neurosci. 2012;35:1871–1878. doi: 10.1111/j.1460-9568.2012.08156.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27.Weinberger D.R. Implications of normal brain development for the pathogenesis of schizophrenia. Arch Gen Psychiatry. 1987;44:660–669. doi: 10.1001/archpsyc.1987.01800190080012. [DOI] [PubMed] [Google Scholar]
  • 28.Sekar A., Bialas A.R., De Rivera H., Davis A., Hammond T.R., Kamitaki N., et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177–183. doi: 10.1038/nature16549. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29.Trubetskoy V., Pardiñas A.F., Qi T., Panagiotaropoulou G., Awasthi S., Bigdeli T.B., et al. Mapping genomic loci implicates genes and synaptic biology in schizophrenia. Nature. 2022;604:502–508. doi: 10.1038/s41586-022-04434-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30.Gandal M.J., Haney J.R., Parikshak N.N., Leppa V., Ramaswami G., Hartl C., et al. Shared molecular neuropathology across major psychiatric disorders parallels polygenic overlap. Science. 2018;359:693–697. [Google Scholar]
  • 31.Boudriot E., Stephan M., Rabe F., Smigielski L., Schmitt A., Falkai P., et al. Genetic analysis of retinal cell types in neuropsychiatric disorders. JAMA Psychiatry. 2025;82:285–295. doi: 10.1001/jamapsychiatry.2024.4230. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32.Di Paolo T., Harnois C., Daigle M. Assay of dopamine and its metabolites in human and rat retina. Neurosci Lett. 1987;74:250–254. doi: 10.1016/0304-3940(87)90158-3. [DOI] [PubMed] [Google Scholar]
  • 33.Brandies R., Yehuda S. The possible role of retinal dopaminergic system in visual performance. Neurosci Biobehav Rev. 2008;32:611–656. doi: 10.1016/j.neubiorev.2007.09.004. [DOI] [PubMed] [Google Scholar]
  • 34.Witkovsky P. Dopamine and retinal function. Doc Ophthalmol. 2004;108:17–39. doi: 10.1023/b:doop.0000019487.88486.0a. [DOI] [PubMed] [Google Scholar]
  • 35.Zhao X., Wong K.Y., Zhang D.-Q. Mapping physiological inputs from multiple photoreceptor systems to dopaminergic amacrine cells in the mouse retina. Sci Rep. 2017;7:7920. doi: 10.1038/s41598-017-08172-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 36.Mariani A.P., Kolb H., Nelson R. Dopamine-containing amacrine cells of rhesus monkey retina parallel rods in spatial distribution. Brain Res. 1984;322:1–7. doi: 10.1016/0006-8993(84)91174-0. [DOI] [PubMed] [Google Scholar]
  • 37.Miyagishima K.J., Lai X., Nath A., Grimes W.N., Ping X., Diamond J.S., et al. Comparative analysis of tyrosine hydroxylase amacrine cells in the mammalian retina: Distribution and quantification in mouse, rat, ground squirrel and macaque retinas. Int J Mol Sci. 2025;26:6972. doi: 10.3390/ijms26146972. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38.Veruki M.L., Wässle H. Immunohistochemical localization of dopamine D1 receptors in rat retina. Eur J Neurosci. 1996;8:2286–2297. doi: 10.1111/j.1460-9568.1996.tb01192.x. [DOI] [PubMed] [Google Scholar]
  • 39.Chaffiol A., Ishii M., Cao Y., Mangel S.C. Dopamine regulation of GABAA receptors contributes to light/dark modulation of the ON-cone bipolar cell receptive field surround in the retina. Curr Biol. 2017;27:2600–2609.e4. doi: 10.1016/j.cub.2017.07.063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40.Peppe A., Antal A., Tagliati M., Stanzione P., Bodis-Wollner I. D1 agonist CY208–243 attenuates the pattern electroretinogram to low spatial frequency stimuli in the monkey. Neurosci Lett. 1998;243:5–8. doi: 10.1016/s0304-3940(98)00068-8. [DOI] [PubMed] [Google Scholar]
  • 41.Ira E., Zanoni M., Ruggeri M., Dazzan P., Tosato S. COMT, neuropsychological function and brain structure in schizophrenia: A systematic review and neurobiological interpretation. J Psychiatry Neurosci. 2013;38:366–380. doi: 10.1503/jpn.120178. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 42.Tunbridge E.M., Narajos M., Harrison C.H., Beresford C., Cipriani A., Harrison P.J. Which dopamine polymorphisms are functional? Systematic review and meta-analysis of COMT, DAT, DBH, DDC, DRD1–5, MAOA, MAOB, TH, VMAT1, and VMAT2. Biol Psychiatry. 2019;86:608–620. doi: 10.1016/j.biopsych.2019.05.014. [DOI] [PubMed] [Google Scholar]
  • 43.van Hooijdonk C.F.M., van der Pluijm M., Bosch I., van Amelsvoort T.A.M.J., Booij J., de Haan L., et al. The substantia nigra in the pathology of schizophrenia: A review on post-mortem and molecular imaging findings. Eur Neuropsychopharmacol. 2023;68:57–77. doi: 10.1016/j.euroneuro.2022.12.008. [DOI] [PubMed] [Google Scholar]
  • 44.McCutcheon R.A., Krystal J.H., Howes O.D. Dopamine and glutamate in schizophrenia: Biology, symptoms and treatment. World Psychiatry. 2020;19:15–33. doi: 10.1002/wps.20693. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 45.Stephan A.H., Barres B.A., Stevens B. The complement system: An unexpected role in synaptic pruning during development and disease. Annu Rev Neurosci. 2012;35:369–389. doi: 10.1146/annurev-neuro-061010-113810. [DOI] [PubMed] [Google Scholar]
  • 46.Do K.Q., Cabungcal J.H., Frank A., Steullet P., Cuenod M. Redox dysregulation, neurodevelopment, and schizophrenia. Curr Opin Neurobiol. 2009;19:220–230. doi: 10.1016/j.conb.2009.05.001. [DOI] [PubMed] [Google Scholar]
  • 47.Smigielski L., Jagannath V., Rössler W., Walitza S., Grünblatt E. Epigenetic mechanisms in schizophrenia and other psychotic disorders: A systematic review of empirical human findings. Mol Psychiatry. 2020;25:1718–1748. doi: 10.1038/s41380-019-0601-3. [DOI] [PubMed] [Google Scholar]
  • 48.Yan Y., Zhaoping L., Li W. Bottom-up saliency and top-down learning in the primary visual cortex of monkeys. Proc Natl Acad Sci USA. 2018;115:10499–10504. doi: 10.1073/pnas.1803854115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 49.Melloni L., van Leeuwen S., Alink A., Müller N.G. Interaction between bottom-up saliency and top-down control: How saliency maps are created in the human brain. Cereb Cortex. 2012;22:2943–2952. doi: 10.1093/cercor/bhr384. [DOI] [PubMed] [Google Scholar]
  • 50.Chun C.A., Brugger P., Kwapil T.R. Aberrant salience across levels of processing in positive and negative schizotypy. Front Psychol. 2019;10:2073. doi: 10.3389/fpsyg.2019.02073. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 51.Crouzet S.M., Thorpe S.J. Low-level cues and ultra-fast face detection. Front Psychology. 2011;2:342. doi: 10.3389/fpsyg.2011.00342. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52.Thorpe S., Fize D., Marlot C. Speed of processing in the human visual system. Nature. 1996;381:520–522. doi: 10.1038/381520a0. [DOI] [PubMed] [Google Scholar]
  • 53.Bar M. From objects to unified minds. Curr Dir Psychol Sci. 2021;30:129–137. [Google Scholar]
  • 54.Levin L.A., Kaufman P.L., Hartnett M.E. Elsevier Health Sciences; Philadelphia, PA: 2024. Adler’s Physiology of the Eye E-Book. [Google Scholar]
  • 55.Atkinson J.R. The perceptual characteristics of voice-hallucinations in deaf people: Insights into the nature of subvocal thought and sensory feedback loops. Schizophr Bull. 2005;32:701–708. doi: 10.1093/schbul/sbj063. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56.Landsberger S.A., Diaz D.R. Identifying and assessing psychosis in deaf psychiatric patients. Curr Psychiatry Rep. 2011;13:198–202. doi: 10.1007/s11920-011-0186-2. [DOI] [PubMed] [Google Scholar]
  • 57.Maison S.F., Liu X.-P., Eatock R.A., Sibley D.R., Grandy D.K., Liberman M.C. Dopaminergic signaling in the cochlea: Receptor expression patterns and deletion phenotypes. J Neurosci. 2012;32:344–355. doi: 10.1523/JNEUROSCI.4720-11.2012. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58.Kapur S. Psychosis as a state of aberrant salience: A framework linking biology, phenomenology, and pharmacology in schizophrenia. Am J Psychiatry. 2003;160:13–23. doi: 10.1176/appi.ajp.160.1.13. [DOI] [PubMed] [Google Scholar]
  • 59.Silverstein S.M., Knight R.A., Schwarzkopf S.B., West L.L., Osborn L.M., Kamin D. Stimulus configuration and context effects in perceptual organization in schizophrenia. J Abnorm Psychol. 1996;105:410–420. doi: 10.1037//0021-843x.105.3.410. [DOI] [PubMed] [Google Scholar]
  • 60.Born R.T., Bencomo G.M. Illusions, delusions, and your backwards Bayesian brain: A biased visual perspective. Brain Behav Evol. 2020;95:272–285. doi: 10.1159/000514859. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61.Mishara A.L. Klaus Conrad (1905–1961): Delusional mood, psychosis, and beginning schizophrenia. Schizophr Bull. 2010;36:9–13. doi: 10.1093/schbul/sbp144. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 62.Javitt D.C., Freedman R. Sensory processing dysfunction in the personal experience and neuronal machinery of schizophrenia. Am J Psychiatry. 2015;172:17–31. doi: 10.1176/appi.ajp.2014.13121691. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 63.Sterzer P., Adams R.A., Fletcher P., Frith C., Lawrie S.M., Muckli L., et al. The predictive coding account of psychosis. Biol Psychiatry. 2018;84:634–643. doi: 10.1016/j.biopsych.2018.05.015. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64.Yin J., Yuan Q. Structural homeostasis in the nervous system: A balancing act for wiring plasticity and stability. Front Cell Neurosci. 2015;8:439. doi: 10.3389/fncel.2014.00439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 65.Kromer J.A., Tass P.A. Long-lasting desynchronization by decoupling stimulation. Phys Rev Research. 2020;2 [Google Scholar]
  • 66.Soyka M., Koch W., Möller H.J., Rüther T., Tatsch K. Hypermetabolic pattern in frontal cortex and other brain regions in unmedicated schizophrenia patients: Results from a FDG–PET study. Eur Arch Psychiatry Clin Neurosci. 2005;255:308–312. doi: 10.1007/s00406-005-0563-0. [DOI] [PubMed] [Google Scholar]
  • 67.Schobel S.A., Lewandowski N.M., Corcoran C.M., Moore H., Brown T., Malaspina D., Small S.A. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Arch Gen Psychiatry. 2009;66:938–946. doi: 10.1001/archgenpsychiatry.2009.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68.Townsend L., Pillinger T., Selvaggi P., Veronese M., Turkheimer F., Howes O. Brain glucose metabolism in schizophrenia: A systematic review and meta-analysis of 18 FDG-PET studies in schizophrenia. Psychol Med. 2023;53:4880–4897. doi: 10.1017/S003329172200174X. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69.Costa K.M., Scholz R., Lloyd K., Moreno-Castilla P., Gardner M.P.H., Dayan P., Schoenbaum G. The role of the lateral orbitofrontal cortex in creating cognitive maps. Nat Neurosci. 2023;26:107–115. doi: 10.1038/s41593-022-01216-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70.Johnson-Laird P.N. Harvard University Press; Cambridge, MA: 1983. Mental Models: Towards a Cognitive Science of Language, Inference, and Consciousness. [Google Scholar]
  • 71.Butz M., Teuchert-Noodt G. A simulation model for compensatory plasticity in the prefrontal cortex inducing a cortico-cortical dysconnection in early brain development. J Neural Transm. 2006;113:695–710. doi: 10.1007/s00702-005-0403-4. [DOI] [PubMed] [Google Scholar]
  • 72.Mastrandrea R., Piras F., Gabrielli A., Banaj N., Caldarelli G., Spalletta G., Gili T. The unbalanced reorganization of weaker functional connections induces the altered brain network topology in schizophrenia. Sci Rep. 2021;11 doi: 10.1038/s41598-021-94825-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73.Zylberberg J., Pouget A., Latham P.E., Shea-Brown E. Robust information propagation through noisy neural circuits. PLoS Comput Biol. 2017;13 doi: 10.1371/journal.pcbi.1005497. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74.Glantz L.A., Lewis D.A. Decreased dendritic spine density on prefrontal cortical pyramidal neurons in schizophrenia. Arch Gen Psychiatry. 2000;57:65–73. doi: 10.1001/archpsyc.57.1.65. [DOI] [PubMed] [Google Scholar]
  • 75.Husain M.O., Jones B., Arshad U., Ameis S.H., Mirfallah G., Schifani C., et al. A systematic review and meta-analysis of neuroimaging studies examining synaptic density in individuals with psychotic spectrum disorders. BMC Psychiatry. 2024;24:460. doi: 10.1186/s12888-024-05788-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76.Roberts R.C., Barksdale K.A., Roche J.K., Lahti A.C. Decreased synaptic and mitochondrial density in the postmortem anterior cingulate cortex in schizophrenia. Schizophr Res. 2015;168:543–553. doi: 10.1016/j.schres.2015.07.016. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77.Haijma S.V., Van Haren N., Cahn W., Koolschijn P.C.M., Hulshoff Pol H.E., Kahn R.S. Brain volumes in schizophrenia: A meta-analysis in over 18 000 subjects. Schizophr Bull. 2013;39:1129–1138. doi: 10.1093/schbul/sbs118. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 78.Onwordi E.C., Whitehurst T., Shatalina E., Carr R., Mansur A., Arumuham A., et al. The relationship between cortical synaptic terminal density marker SV2A and glutamate early in the course of schizophrenia: A multimodal PET and MRS imaging study. Transl Psychiatry. 2025;15:70. doi: 10.1038/s41398-025-03269-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79.Parnaudeau S., Bolkan S.S., Kellendonk C. The mediodorsal thalamus: An essential partner of the prefrontal cortex for cognition. Biol Psychiatry. 2018;83:648–656. doi: 10.1016/j.biopsych.2017.11.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 80.Béhuret S., Deleuze C., Bal T. Corticothalamic synaptic noise as a mechanism for selective attention in thalamic neurons. Front Neural Circuits. 2015;9:80. doi: 10.3389/fncir.2015.00080. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81.Bolkan S.S., Stujenske J.M., Parnaudeau S., Spellman T.J., Rauffenbart C., Abbas A.I., et al. Thalamic projections sustain prefrontal activity during working memory maintenance. Nat Neurosci. 2017;20:987–996. doi: 10.1038/nn.4568. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82.Kara P., Reinagel P., Reid R.C. Low response variability in simultaneously recorded retinal, thalamic, and cortical neurons. Neuron. 2000;27:635–646. doi: 10.1016/s0896-6273(00)00072-6. [DOI] [PubMed] [Google Scholar]
  • 83.Tau G.Z., Peterson B.S. Normal development of brain circuits. Neuropsychopharmacology. 2010;35:147–168. doi: 10.1038/npp.2009.115. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 84.Xie C., Xiang S., Shen C., Peng X., Kang J., Li Y., et al. A shared neural basis underlying psychiatric comorbidity. Nat Med. 2023;29:1232–1242. doi: 10.1038/s41591-023-02317-4. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 85.Sakai J. How synaptic pruning shapes neural wiring during development and, possibly, in disease. Proc Natl Acad Sci USA. 2020;117:16096–16099. doi: 10.1073/pnas.2010281117. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86.Faust T.E., Gunner G., Schafer D.P. Mechanisms governing activity-dependent synaptic pruning in the developing mammalian CNS. Nat Rev Neurosci. 2021;22:657–673. doi: 10.1038/s41583-021-00507-y. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 87.Lehrman E.K., Wilton D.K., Litvina E.Y., Welsh C.A., Chang S.T., Frouin A., et al. CD47 protects synapses from excess microglia-mediated pruning during development. Neuron. 2018;100:120–134.e6. doi: 10.1016/j.neuron.2018.09.017. e126. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88.Schafer D.P., Lehrman E.K., Kautzman A.G., Koyama R., Mardinly A.R., Yamasaki R., et al. Microglia sculpt postnatal neural circuits in an activity and complement-dependent manner. Neuron. 2012;74:691–705. doi: 10.1016/j.neuron.2012.03.026. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89.Stevens B., Allen N.J., Vazquez L.E., Howell G.R., Christopherson K.S., Nouri N., et al. The classical complement cascade mediates CNS synapse elimination. Cell. 2007;131:1164–1178. doi: 10.1016/j.cell.2007.10.036. [DOI] [PubMed] [Google Scholar]
  • 90.Yilmaz M., Yalcin E., Presumey J., Aw E., Ma M., Whelan C.W., et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214–224. doi: 10.1038/s41593-020-00763-8. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91.Gangadin S.S., Germann M., de Witte L.D., Gelderman K.A., Mandl R.C.W., Sommer I.E.C. Complement component 4A protein levels are negatively related to frontal volumes in patients with schizophrenia spectrum disorders. Schizophr Res. 2023;261:6–14. doi: 10.1016/j.schres.2023.08.031. [DOI] [PubMed] [Google Scholar]
  • 92.Hatzimanolis A., Foteli S., Stefanatou P., Ntigrintaki A.-A., Ralli I., Kollias K., et al. Deregulation of complement components C4A and CSMD1 peripheral expression in first-episode psychosis and links to cognitive ability. Eur Arch Psychiatry Clin Neurosci. 2022;272:1219–1228. doi: 10.1007/s00406-022-01409-5. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93.Jiang Y., Luo C., Li X., Duan M., He H., Chen X., et al. Progressive reduction in gray matter in patients with schizophrenia assessed with MR imaging by using causal network analysis. Radiology. 2018;287:729. doi: 10.1148/radiol.2018184005. [DOI] [PubMed] [Google Scholar]
  • 94.Vita A., De Peri L., Deste G., Sacchetti E. Progressive loss of cortical gray matter in schizophrenia: A meta-analysis and meta-regression of longitudinal MRI studies. Transl Psychiatry. 2012;2:e190. doi: 10.1038/tp.2012.116. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 95.Kuroki N., Shenton M.E., Salisbury D.F., Hirayasu Y., Onitsuka T., Ersner H., et al. Middle and inferior temporal gyrus gray matter volume abnormalities in first-episode schizophrenia: An MRI study. Am J Psychiatry. 2006;163:2103–2110. doi: 10.1176/appi.ajp.163.12.2103. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 96.Tohid H., Faizan M., Faizan U. Alterations of the occipital lobe in schizophrenia. NSJ. 2015;20:213–224. doi: 10.17712/nsj.2015.3.20140757. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97.Turrigiano G.G. The self-tuning neuron: Synaptic scaling of excitatory synapses. Cell. 2008;135:422–435. doi: 10.1016/j.cell.2008.10.008. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98.Gogtay N., Giedd J.N., Lusk L., Hayashi K.M., Greenstein D., Vaituzis A.C., et al. Dynamic mapping of human cortical development during childhood through early adulthood. Proc Natl Acad Sci USA. 2004;101:8174–8179. doi: 10.1073/pnas.0402680101. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99.Petanjek Z., Judaš M., Šimić G., Rašin M.R., Uylings H.B.M., Rakic P., Kostović I. Extraordinary neoteny of synaptic spines in the human prefrontal cortex. Proc Natl Acad Sci USA. 2011;108:13281–13286. doi: 10.1073/pnas.1105108108. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100.Kahn R.S., Keefe R.S.E. Schizophrenia is a cognitive illness: Time for a change in focus. JAMA Psychiatry. 2013;70:1107–1112. doi: 10.1001/jamapsychiatry.2013.155. [DOI] [PubMed] [Google Scholar]
  • 101.Gonzalez-Burgos G., Cho R.Y., Lewis D.A. Alterations in cortical network oscillations and parvalbumin neurons in schizophrenia. Biol Psychiatry. 2015;77:1031–1040. doi: 10.1016/j.biopsych.2015.03.010. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 102.Lewis D.A., Hashimoto T., Volk D.W. Cortical inhibitory neurons and schizophrenia. Nat Rev Neurosci. 2005;6:312–324. doi: 10.1038/nrn1648. [DOI] [PubMed] [Google Scholar]
  • 103.Blasco M.B., Nisha Aji K., Ramos-Jiménez C., Leppert I.R., Tardif C.L., Cohen J., et al. Synaptic density in early stages of psychosis and clinical high risk. JAMA Psychiatry. 2025;82:171–180. doi: 10.1001/jamapsychiatry.2024.3608. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104.Myin-Germeys I., Delespaul P., Van Os J. Behavioural sensitization to daily life stress in psychosis. Psychol Med. 2005;35:733–741. doi: 10.1017/s0033291704004179. [DOI] [PubMed] [Google Scholar]
  • 105.Reeve S., Sheaves B., Freeman D. The role of sleep dysfunction in the occurrence of delusions and hallucinations: A systematic review. Clin Psychol Rev. 2015;42:96–115. doi: 10.1016/j.cpr.2015.09.001. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 106.Laruelle M. The role of endogenous sensitization in the pathophysiology of schizophrenia: Implications from recent brain imaging studies. Brain Res Rev. 2000;31:371–384. doi: 10.1016/s0165-0173(99)00054-5. [DOI] [PubMed] [Google Scholar]
  • 107.Kantrowitz J.T., Butler P.D., Schecter I., Silipo G., Javitt D.C. Seeing the world dimly: The impact of early visual deficits on visual experience in schizophrenia. Schizophr Bull. 2009;35:1085–1094. doi: 10.1093/schbul/sbp100. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 108.Chung L.K.-H., Whitford T.J., Chau A.K.C., Chan S.S.-M., Chong G.H.-C., So S.H.-W. Momentary dynamics of inner speech varieties, auditory verbal hallucinations, and affect in schizophrenia spectrum disorders: An experience sampling study. Psychol Med. 2026;56:1–12. doi: 10.1017/S0033291725102985. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 109.Alderson-Day B., Fernyhough C. Inner speech: Development, cognitive functions, phenomenology, and neurobiology. Psychol Bull. 2015;141:931–965. doi: 10.1037/bul0000021. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 110.Frith C. Explaining delusions of control: The comparator model 20years on. Conscious Cogn. 2012;21:52–54. doi: 10.1016/j.concog.2011.06.010. [DOI] [PubMed] [Google Scholar]
  • 111.Arnal L.H., Flinker A., Kleinschmidt A., Giraud A.-L., Poeppel D. Human screams occupy a privileged niche in the communication soundscape. Curr Biol. 2015;25:2051–2056. doi: 10.1016/j.cub.2015.06.043. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 112.Bach D.R., Schächinger H., Neuhoff J.G., Esposito F., Di Salle F., Lehmann C., et al. Rising sound intensity: An intrinsic warning cue activating the amygdala. Cerebral Cortex. 2008;18:145–150. doi: 10.1093/cercor/bhm040. [DOI] [PubMed] [Google Scholar]
  • 113.Jefsen O.H., Petersen L.V., Bek T., Østergaard S.D. Is early blindness protective of psychosis or are we turning a blind eye to the lack of statistical power? Schizophrenia Bulletin. 2020;46:1335–1336. doi: 10.1093/schbul/sbaa048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 114.Silverstein S.M., Lai A. The phenomenology and neurobiology of visual distortions and hallucinations in schizophrenia: An update. Front Psychiatry. 2021;12 doi: 10.3389/fpsyt.2021.684720. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 115.David C.N., Greenstein D., Clasen L., Gochman P., Miller R., Tossell J.W., et al. Childhood onset schizophrenia: High rate of visual hallucinations. J Am Acad Child Adolesc Psychiatry. 2011;50:681–686.e3. doi: 10.1016/j.jaac.2011.03.020. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 116.Waters F., Collerton D., Ffytche D.H., Jardri R., Pins D., Dudley R., et al. Visual hallucinations in the psychosis spectrum and comparative information from neurodegenerative disorders and eye disease. Schizophr Bull. 2014;40(suppl 4):S233–S245. doi: 10.1093/schbul/sbu036. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 117.Singh T., Poterba T., Curtis D., Akil H., Al Eissa M., Barchas J.D., et al. Rare coding variants in ten genes confer substantial risk for schizophrenia. Nature. 2022;604:509–516. doi: 10.1038/s41586-022-04556-w. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 118.Melbourne J.K., Rosen C., Feiner B., Sharma R.P. C4A mRNA expression in PBMCs predicts the presence and severity of delusions in schizophrenia and bipolar disorder with psychosis. Schizophr Res. 2018;197:321–327. doi: 10.1016/j.schres.2018.01.018. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 119.Manford M., Andermann F. Complex visual hallucinations. Clinical and neurobiological insights. Brain: J Neurol. 1998;121:1819–1840. doi: 10.1093/brain/121.10.1819. [DOI] [PubMed] [Google Scholar]
  • 120.Herrero P., Contador I., Stern Y., Fernández-Calvo B., Sánchez A., Ramos F. Influence of cognitive reserve in schizophrenia: A systematic review. Neurosci Biobehav Rev. 2020;108:149–159. doi: 10.1016/j.neubiorev.2019.10.019. [DOI] [PubMed] [Google Scholar]
  • 121.Varese F., Smeets F., Drukker M., Lieverse R., Lataster T., Viechtbauer W., et al. Childhood adversities increase the risk of psychosis: A meta-analysis of patient-control, prospective- and cross-sectional cohort studies. Schizophr Bull. 2012;38:661–671. doi: 10.1093/schbul/sbs050. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 122.Turetsky B.I., Calkins M.E., Light G.A., Olincy A., Radant A.D., Swerdlow N.R. Neurophysiological endophenotypes of schizophrenia: The viability of selected candidate measures. Schizophr Bull. 2006;33:69–94. doi: 10.1093/schbul/sbl060. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 123.Lizano P., Bannai D., Lutz O., Kim L.A., Miller J., Keshavan M. A meta-analysis of retinal cytoarchitectural abnormalities in schizophrenia and bipolar disorder. Schizophr Bull. 2020;46:43–53. doi: 10.1093/schbul/sbz029. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 124.Sheehan N., Bannai D., Silverstein S.M., Lizano P. Neuroretinal alterations in schizophrenia and bipolar disorder: An updated meta-analysis. Schizophr Bull. 2024;50:1067–1082. doi: 10.1093/schbul/sbae102. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 125.Hébert M., Mérette C., Gagné A.-M., Paccalet T., Moreau I., Lavoie J., Maziade M. The electroretinogram may differentiate schizophrenia from bipolar disorder. Biol Psychiatry. 2020;87:263–270. doi: 10.1016/j.biopsych.2019.06.014. [DOI] [PubMed] [Google Scholar]
  • 126.Schallmo M.-P., Sponheim S.R., Olman C.A. Reduced contextual effects on visual contrast perception in schizophrenia and bipolar affective disorder. Psychol Med. 2015;45:3527–3537. doi: 10.1017/S0033291715001439. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 127.Chkonia E., Roinishvili M., Makhatadze N., Tsverava L., Stroux A., Neumann K., et al. The shine-through masking paradigm is a potential endophenotype of schizophrenia. PLoS One. 2010;5 doi: 10.1371/journal.pone.0014268. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 128.Geljic M., Mitchell M., Stevens K.-A., Holbrook H., Darke H., Goodbourn P., et al. Visual integration deficits associated with psychosis are independent of diagnosis. Schizophrenia. 2025;11:58. doi: 10.1038/s41537-025-00606-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 129.Chkonia E., Roinishvili M., Reichard L., Wurch W., Puhlmann H., Grimsen C., et al. Patients with functional psychoses show similar visual backward masking deficits. Psychiatry Res. 2012;198:235–240. doi: 10.1016/j.psychres.2012.02.020. [DOI] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Supplemental Text
mmc1.pdf (189.4KB, pdf)

Articles from Biological Psychiatry Global Open Science are provided here courtesy of Elsevier

RESOURCES